Yüklüyor......
Low dose of apatinib in treating chemotherapy and EGFR-TKI refractory non-small cell lung cancer: A case report
RATIONALE: Lung cancer is the leading cause of cancer-associated deaths all over the world. Although the prognosis of lung cancer has improved over the past decade due to progression in surgical techniques and systematic treatments, the patients with advanced disease still suffer poor survival. Ther...
Kaydedildi:
| Yayımlandı: | Medicine (Baltimore) |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Health
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6380768/ https://ncbi.nlm.nih.gov/pubmed/30702616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000014328 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|